{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:03:36Z","timestamp":1791140616682,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1097\/01.mbc.0000164431.98169.8f","type":"journal-article","created":{"date-parts":[[2005,3,28]],"date-time":"2005-03-28T04:01:36Z","timestamp":1111982496000},"page":"209-214","source":"Crossref","is-referenced-by-count":41,"title":["Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation"],"prefix":"10.1097","volume":"16","author":[{"given":"Junette S","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bareford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Blann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","first-page":"703","article-title":"Pathogenesis of vaso-occlusion","author":"Embury","year":"1994"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur J Haematol"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000046509","article-title":"Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients","volume":"104","author":"Makis","year":"2000","journal-title":"Acta Haematol"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/jcp.45.10.902","article-title":"Subclinical ischaemic episodes during the steady state of sickle cell anaemia","volume":"45","author":"Akinola","year":"1992","journal-title":"J Clin Pathol"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.mbc.0000061293.28953.8c","article-title":"Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity","volume":"14","author":"Blann","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)90418-G","article-title":"Is there an acute-phase response in steady-state sickle cell disease?","volume":"341","author":"Singhal","year":"1993","journal-title":"Lancet"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anaemia","volume":"337","author":"Solovey","year":"1997","journal-title":"N Engl J Med"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001721-199504000-00001","article-title":"Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls","volume":"6","author":"Hagger","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V97.6.1584","article-title":"Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation","volume":"97","author":"Belhassen","year":"2001","journal-title":"Blood"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/15513810109168817","article-title":"Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells","volume":"20","author":"Brown","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"Sultana","year":"1998","journal-title":"Blood"},{"key":"R13-9-20210203","first-page":"169","article-title":"Enhanced thrombin generation in children with sickle cell disease","volume":"71","author":"Peters","year":"1994","journal-title":"Thromb Haemost"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/clin.1996.0163","article-title":"Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis","volume":"81","author":"Duits","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2141.1996.d01-1486.x","article-title":"The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules","volume":"92","author":"Blann","year":"1996","journal-title":"Br J Haematol"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0038-1657624","article-title":"Tissue factor: a complex biological role","volume":"78","author":"Osterud","year":"1997","journal-title":"Thromb Haemost"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(87)91413-9","article-title":"Serum levels of interleukin-6 and acute phase responses [Letter]","volume":"2","author":"Nijsten","year":"1987","journal-title":"Lancet"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/qjmed\/hcg134","article-title":"C-reactive protein and cardiovascular disease: new insights from an old molecule","volume":"96","author":"Hirschfield","year":"2003","journal-title":"Q J Med"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(75)92650-1","article-title":"Factor-VIII complex and endothelial damage [Letter]","volume":"1","author":"Boneu","year":"1975","journal-title":"Lancet"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0006-291X(92)91234-H","article-title":"Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells","volume":"187","author":"Pigott","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ajh.2830420409","article-title":"Antiphospholipid antibodies in sickle cell disease","volume":"42","author":"Kucuk","year":"1993","journal-title":"Am J Hematol"},{"key":"R28-9-20210203","first-page":"611","article-title":"Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease","volume":"84","author":"Francis","year":"1992","journal-title":"J Natl Med Assoc"},{"key":"R29-9-20210203","first-page":"571","article-title":"Protein S deficiency in sickle cell anamia","volume":"111","author":"Francis","year":"1988","journal-title":"J Lab Clin Med"},{"key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.1997.2663083.x","article-title":"Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels?","volume":"98","author":"Wright","year":"1997","journal-title":"Br J Haematol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mbc.0000164431.98169.8f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:46:24Z","timestamp":1785851184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200504000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000164431.98169.8f","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}